The voice of medical practices in Washington

Press Statement

May 3, 2023: MGMA statement on latest data on prior authorization within the Medicare Advantage program

Press Statement

April 6, 2023: MGMA statement on the Strengthening Medicare for Patients and Providers Act (H.R. 2474)

Press Statement

April 5, 2023: MGMA statement on prior authorization policies in the 2024 MA and Part D final rule

Press Statement

March 15, 2023: MGMA statement on March 2023 MedPAC report

Press Statement

January 18, 2023: MGMA statement on 2023 advocacy priorities

Press Statement

December 20, 2022: MGMA statement on Medicare cut provisions included in omnibus draft

Press Statement

December 6, 2022: MGMA statement on CMS’ electronic prior authorization proposed rule

Press Statement

November 1, 2022: MGMA statement on CMS' final 2023 Medicare Physician Fee Schedule

Press Statement

October 11, 2022: Medical Practices Report Significant Increase in Regulatory Burden

Press Statement

September 21, 2022: MGMA statement on Medicare payment reduction findings

Press Statement

September 14, 2022: MGMA statement on House passage of the Improving Seniors' Timely Access to Care Act

Press Statement

September 13, 2022: MGMA statement on the Supporting Medicare Providers Act of 2022

Press Statement

July 27, 2022: MGMA statement on the Improving Seniors' Timely Access to Care Act

Press Statement

July 7, 2022: MGMA statement on CMS' proposed 2023 Medicare Physician Fee Schedule

Press Statement

March 15, 2022: MGMA Statement on MedPAC's March 2022 Report to Congress

Press Statement

March 3, 2022: MGMA Statement on Latest Prior Authorization Data

Press Statement

February 2, 2022: MGMA Statement on the Introduction of the SURS Extension Act

Press Release

January 6, 2022: MGMA Statement on Health Care Value Week

Press Statement

December 9, 2021: MGMA Statement on Passage of Legislation Largely Averting Cuts to Medicare

Press Statement

December 2, 2021: MGMA Statement on Congress's Failure to Avert Medicare Cuts

Press Statement

November 17, 2021: MGMA Statement on the Introduction of Cures 2.0

Press Statement

October 20, 2021: MGMA Statement on Introduction of Prior Auth. Reform Bill in Senate

Press Statement

August 13, 2021: MGMA calls for prohibition on insurers charging EFT fees

Press Statement

August 4, 2021: MGMA statement in support of medical group COVID-19 vaccination policies

Press Statement

July 13, 2021: MGMA statement in response to CMS' proposed 2022 physician fee schedule rule

Press Statement

May 20, 2021: New MGMA Poll Shows Prior Authorization on the Rise Despite COVID-19 Pandemic

Press Statement

May 13, 2021: MGMA statement on House of Representatives’ proposal to address Medicare Advantage plan prior authorization abuses

Press Statement

May 5, 2021: MGMA statement and comment letter to HHS/OCR Re: proposed modifications to the HIPAA Privacy Rule

Advocacy Statement

April 13, 2021: MGMA applauds passage of legislation that extends the 2% Medicare sequester moratorium

Advocacy Statement

March 16, 2021: MGMA statement on Medicare sequester cuts

Advocacy Statement

March 15, 2021: MGMA statement on MedPAC’s Medicare payment policy recommendations

Advocacy Statement

March 2, 2021: MGMA statement on the Subcommittee on Health of the Committee on Energy and Commerce’s hearing on the future of telehealth

Advocacy Statement

Jan. 15, 2021: MGMA statement on CMS Interoperability and Prior Authorization final rule

Jan. 4, 2021: MGMA statement on CMS proposed rule on prior authorization

Advocacy Statement

Jan. 4, 2021: MGMA statement on COVID-19 vaccine rollout status

Advocacy Statement

December 22, 2020: MGMA statement on Congress’ COVID-19 Stimulus Package

Advocacy Statement

December 18, 2020: MGMA statement on Senate Proposal to Address Prior Authorization

December 10, 2020: MGMA statement on the CMS Proposed Rule on Reducing Provider Burden

December 10, 2020: MGMA statement on the Office for Civil Rights HIPAA Proposed Rule

Advocacy Statement

December 1, 2020: MGMA statement on the 2021 Physician Fee Schedule Final Rule

Advocacy Statement

November 23, 2020: MGMA statement on ‘Most Favored Nation’ Interim Final Rule

November 23, 2020: MGMA statement on the Physician Self-referral (Stark) Law and Anti-kickback Statute

Advocacy Statement

November 19, 2020: Leading Health Groups Urge Congress to Maintain Value-based Care Incentives Beyond COVID-19

Advocacy Statement

November 13, 2020: MGMA asks Congress to extend the moratorium on Medicare sequestration cuts

Advocacy Statement

November 10, 2020: MGMA statement on the ONC Task Force Report on Prior Authorization

Advocacy Statement

October 29, 2020: MGMA statement on the ONC interim final rule delaying information blocking requirements until April 5, 2021

Advocacy Statement

October 22, 2020: MGMA poll shows strong opposition to government mandated APMs

Advocacy Statement

October 1, 2020: MGMA Comments to CMS on Proposed 2021 Physician Fee Schedule

Advocacy Statement

July 24, 2020: Press statement on MGMA and coalition supporting the Value in Health Care Act

Advocacy Statement

April 14, 2020: MGMA survey sheds light on dire financial impact of COVID-19 on physician practices

Advocacy Statement

April 10, 2020: MGMA statement in response to HHS's initial distribution of $30 billion in grant funds for providers under the CARES Act

Advocacy Statement

March 27, 2020: MGMA statement on emergency funding for medical practices

Advocacy Statement

March 9, 2020: MGMA statement on ONC and CMS interoperability rules

Advocacy Statement

January 21, 2020: MGMA alarmed by new evidence of increasing prior authorization costs for physician practices

Advocacy Statement

October 14, 2019: MGMA survey finds significant increase in regulatory burden on medical practices

Advocacy Statement

October 9, 2019: MGMA statement on CMS' proposed Physician Self-Referral (Stark) rule

Advocacy Statement

September 25, 2019: MGMA statement on CMS proposed physician fee schedule & QPP

Advocacy Statement

September 23, 2019: MGMA Statement on Concerns Regarding ONC's Implementation of 21st Century Cures Act

Advocacy Statement

June 5, 2019: MGMA applauds new prior authorization bill

Advocacy Statement

May 30, 2019: MGMA supports Administration’s interoperability goals, cautions against added cost, complexity, security risks

Advocacy Statement

MGMA 2019 Advocacy Agenda

Advocacy Statement

May 8, 2019: MGMA statement before the U.S. Senate Committee on Finance

Advocacy Statement

November 1, 2018: MGMA statement on 2019 Medicare Physician Fee Schedule Final Rule

Advocacy Statement

September 20, 2018: MGMA and stakeholder group urge CMS to ensure continued success of ACO program

Advocacy Statement

September 11, 2018: 28 Physician Groups Ask Congress for AUC Program Relief

Advocacy Statement

July 12, 2018: MGMA statement on Release of Physician Fee Schedule Proposed Rule

Advocacy Statement

May 24, 2018: MGMA outlines physician group practice priorities in CMS’ proposed direct contracting model

Advocacy Statement

May 23, 2018: MGMA statement on passage of the VA Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018

Advocacy Statement

March 22, 2018: MGMA statement for Ways and Means MACRA implementation hearing

Advocacy Statement

March 15, 2018: MGMA statement on Ways and Means Medicare Red Tape Relief Initiative

Advocacy Statement

March 15, 2018: MGMA comment on the MedPAC March 2018 report to Congress

Advocacy Statement

March 1, 2018: MGMA Poll: Medical group practices oppose mandatory Medicare alternative payment models

Advocacy Statement

January 17, 2018: MGMA statement following the bipartisan Senate Finance committee vote to advance the nomination of Alex Azar for HHS Secretary